Cefotaxime Sodium

Spécifications

64485-93-4Numéro CAS

264-915-9Numéro CE

sodium (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateNom IUPAC

C16H16N5NaO7S2Formule chimique

477.5 g/molMasse molaire

CEFOTAXIME SODIUM; 64485-93-4; CEFOTAXIME SODIUM SALT; Sodium cefotaxime; Pretor; (+)-Cefotaxime sodium salt; HR 756; DTXSID4046991; RU 24756; HR-756; 258J72S7TZ; HR756; Ru-24756; NSC-756666; Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate; CHEBI:3498; DTXCID201476109; Cefotaxime and dextrose 2.4% in plastic container; Cefotaxime and dextrose 3.9% in plastic container; CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER; CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; Cefcil; Sodium, Cefotaxime; cefotaxime injection; RefChem:54735; Ru24756; Monosodium (6R,7R)-3-acetoxymethyl-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetylamino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Tolycar; Cefotax; Claforan; Cefotaxime (sodium); MFCD00079073; MLS000028559; sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; SMR000058812; sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Ralopar; Tolycor; Zariviz; Claforan sodium; Cefotaxim sodium; MLS002222330; sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefotaxime sodium salt (syn-isomer); SMR001307269; Ceftoringe; Califrid; Cefacron; Cefantral; Cefomed; Cefomerc; Cefotam; Cefoxim; Cefronate; Chemcef; Clafora; Claftax; Eaxiron; Elkotak; Epotazime; Evotaxime; Novatax; Oritaxim; Sefagen; Zafixime; Biolog; Biotax; Bioxim; Calcef; Cefcan; Ceftim; Ceftop; Clavox; Fortax; Baxim; Cefon; Excef; Forax; UNII-258J72S7TZ; CefSo; NCGC00017128-01; Claforan (TN); Prestwick_823; Cefotaxime sodium [USAN:USP:JAN]; EINECS 264-915-9; CAS-64485-93-4; Cefotaxime sodium CRS; Opera_ID_1945; Cefotaxime Sodium (sterile); CHEMBL1010; SCHEMBL41092; MSK10011Na; MLS001077352; MLS001333684; orb1224364; orb1310177; orb3025809; Cefotaxime (sodium) (Standard); CEFOTAXIME SODIUM [JAN]; Cefotaxime sodium (JP18/USP); CEFOTAXIME SODIUM [USAN]; HY-A0088R; Cefotaxime sodium [EP monograph]; CEFOTAXIME SODIUM [VANDF]; Cefotaxime sodium - Sterile grade; CEFOTAXIME SODIUM [MART.]; HMS1568K20; HMS2095K20; HMS2233J21; HMS3260H18; HMS3712K20; CEFOTAXIME SODIUM [USP-RS]; CEFOTAXIME SODIUM [WHO-DD]; CEFOTAXIME SODIUM SALT [MI]; HY-A0088; Tox21_110791; Tox21_500278; s4517; AKOS015951272; Cefotaxime for peak identification CRS; AC11346; CCG-220139; CCG-221582; CEFOTAXIME SODIUM [EP IMPURITY]; CEFOTAXIME SODIUM [ORANGE BOOK]; CS-4297; KS-1416; NSC 756666; CEFOTAXIME SODIUM [USP IMPURITY]; CEFOTAXIME SODIUM [USP MONOGRAPH]; NCGC00093734-01; NCGC00093734-02; NCGC00260963-01; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-; AC165016; SMR000653480; Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(Z)-(O-methyloxime), acetate (ester); C2224; CEFOTAXIME SODIUM, REFERENCE STANDARD; EU-0100278; C 7912; C08113; D00919; F90396; EN300-25953723; Cefotaxime sodium salt, potency: 916-964 mug per mg; Q27106109; Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard; Cefotaxime sodium salt, plant cell culture tested, BioReagent, powder; Cefotaxime sodium, United States Pharmacopeia (USP) Reference Standard; Cefotaxime for peak identification, European Pharmacopoeia (EP) Reference Standard; ([6R-[6alpha,7beta(z)]]-3-[(Acetyloxy)methyl]-[[(2-amine-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid monosodium salt; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-8-oxo-,?sodium salt, (6R,7R)- (1:1); SODIUM (6R,7R)-3-(ACETOXYMETHYL)-7-((E)-2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE; sodium (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Sodium (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Sodium (6R-(6alpha,7beta(Z)))-3-(acetoxymethyl)-7-((2-aminothiazol-4-yl)(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; sodium 3-(acetoxymethyl)-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylateSynonymes